Concepedia

Shelley Hull

SH

Statistics

Publications

2

Citations

474

H-Index

2

Active since

1999

Affiliations

Duke Medical Center(Current)

Shelley Hull is an author at Duke Medical Center specializing in oncology, tumor antigen recognition, and immunology.

Publications per year

1999–1999

2

Publications

2

A Phase I study of active immunotherapy with carcinoembryonic antigen peptide (CAP-1)-pulsed, autologous human cultured dendritic cells in patients with metastatic malignancies expressing carcinoembryonic antigen.

Michael A. Morse, Yuping Deng, D Coleman et al. · PubMed · 1999 · 300 citations

, , +17

Induction of carcinoembryonic antigen (cea)-specific cytotoxic t-lymphocyte responsesIn vitro using autologous dendritic cells loaded with cea peptide or cea rna in patients with metastatic malignancies expressing cea

Smita K. Nair, Shelley Hull, Doris Coleman et al. · International Journal of Cancer · 1999 · 174 citations · Full text

, , +17

1–2 of 2